# An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

> **NCT07132645** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Neuroendocrine Tumor

## Interventions

- **PROCEDURE:** Computed Tomography
- **DRUG:** Gallium Ga 68-DOTA-FAPI-04
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT07132645
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-16
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07132645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07132645, "An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07132645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*